Literature DB >> 14695337

Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.

Xian Wu Cheng1, Masafumi Kuzuya, Takeshi Sasaki, Koji Arakawa, Shigeru Kanda, Daigo Sumi, Teruhiko Koike, Keiko Maeda, Norika Tamaya-Mori, Guo-Ping Shi, Noboru Saito, Akihisa Iguchi.   

Abstract

The matrix-degrading activity of several proteases are involved in the accelerated breakdown of extracellular matrix associated with vascular remodeling during the development of atherosclerosis and vascular injury-induced neointimal formation. Previous studies have shown that the potent elastolytic cysteine proteases, cathepsins S and K, are overexpressed in atherosclerotic lesions in human and animal models. However, the role of these cathepsins in vascular remodeling remains unclear. In the present study, the expressions of cathepsin S and K and their inhibitor cystatin C were examined during arterial remodeling using a rat carotid artery balloon-injury model. The increase in both cathepsin S and K mRNA levels was observed from day 1 and day 3 through day 14 following the induction of balloon injury, respectively. Western blotting analysis revealed that both cathepsin S and K protein levels also increased in the carotid arteries during neointima formation, coinciding with an increase elastolytic activity assayed using Elastin-Congo red, whereas, no significant change in the expressions of cystatin C mRNA and protein was observed during follow-up periods after injury. Immunohistochemistry, Western blot, and in situ hybridization showed that the increase of cathepins S and K and the decrease of cystatin C occurred preferentially in the developing neointima. These findings suggest that cathepsin S and K may participate in the pathological arterial remodeling associated with restenosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695337      PMCID: PMC1602234          DOI: 10.1016/S0002-9440(10)63114-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Emerging roles for cysteine proteases in human biology.

Authors:  H A Chapman; R J Riese; G P Shi
Journal:  Annu Rev Physiol       Date:  1997       Impact factor: 19.318

2.  Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.

Authors:  W Kafienah; D Brömme; D J Buttle; L J Croucher; A P Hollander
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.

Authors:  P Carmeliet; L Moons; R Lijnen; M Baes; V Lemaître; P Tipping; A Drew; Y Eeckhout; S Shapiro; F Lupu; D Collen
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

4.  Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9.

Authors:  R D Kenagy; C E Hart; W G Stetler-Stevenson; A W Clowes
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

5.  Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification.

Authors:  M J Bossard; T A Tomaszek; S K Thompson; B Y Amegadzie; C R Hanning; C Jones; J T Kurdyla; D E McNulty; F H Drake; M Gowen; M A Levy
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

Review 6.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

7.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.

Authors:  G K Sukhova; G P Shi; D I Simon; H A Chapman; P Libby
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

8.  Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo.

Authors:  L Cheng; G Mantile; R Pauly; C Nater; A Felici; R Monticone; C Bilato; Y A Gluzband; M T Crow; W Stetler-Stevenson; M C Capogrossi
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

9.  The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA.

Authors:  I Olafsson
Journal:  Scand J Clin Lab Invest       Date:  1995-11       Impact factor: 1.713

10.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat.

Authors:  M P Bendeck; N Zempo; A W Clowes; R E Galardy; M A Reidy
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

View more
  29 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

2.  Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.

Authors:  Yusuke Izumi; Mutsuharu Hayashi; Ryota Morimoto; Xian Wu Cheng; Hongxian Wu; Hideki Ishii; Yoshinari Yasuda; Daiji Yoshikawa; Hideo Izawa; Seiichi Matsuo; Yutaka Oiso; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

4.  Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Authors:  Xian Wu Cheng; Masafumi Kuzuya; Kae Nakamura; Qun Di; Zexuan Liu; Takeshi Sasaki; Shigeru Kanda; Hai Jin; Guo-Ping Shi; Toyoaki Murohara; Mitsuhiro Yokota; Akihisa Iguchi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 5.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 6.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 7.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

8.  Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Authors:  Nicholas A Dewyer; Vikram Sood; Erin M Lynch; Catherine E Luke; Gilbert R Upchurch; Thomas W Wakefield; Steven Kunkel; Peter K Henke
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

9.  Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.

Authors:  Xian Wu Cheng; Toyoaki Murohara; Masafumi Kuzuya; Hideo Izawa; Takeshi Sasaki; Koji Obata; Kohzo Nagata; Takao Nishizawa; Masakazu Kobayashi; Takashi Yamada; Weon Kim; Kohji Sato; Guo-Ping Shi; Kenji Okumura; Mitsuhiro Yokota
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

10.  Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells.

Authors:  Manu O Platt; Catera L Wilder; Alan Wells; Linda G Griffith; Douglas A Lauffenburger
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.